Overview
This study conduct a two-arm, parallel-group randomized controlled trial. The study will recruit and randomize 900 smokers (n=450 per arm) to either: (1) Control: Standard Smoking Cessation Counseling or (2) Intervention: Integrated Financial-Smoking Cessation Counseling.
Description
The study is a two-arm, parallel-group RCT. The study will recruit and randomize 900 low-income smokers (n=450 per arm) to either: (1) Control: Standard Smoking Cessation Counseling or (2) Intervention: Integrated Financial-Smoking Cessation Counseling. Both groups will receive 8 weeks of nicotine replacement therapy. The study will survey participants at baseline, 6 months, and 12 months to assess outcomes and mechanisms, and biochemically verify self-reported abstinence at 12 months (our primary outcome). The study will assess and compare the costs and cost-per-quit in the two treatment arms.
Eligibility
Inclusion Criteria:
- age ≥18 years,
- smokes ≥5 cigarettes per day,
- interested in receiving smoking and financial counseling,
- self-reported income below 200% of the current federal poverty level,
- New York City resident,
- speaks English or Spanish language (the interventions and measures have not been validated in other languages),
- able to provide informed consent, and
- does not have a representative who manages his/her funds.
Exclusion Criteria
- people who know a current past study participant (to avoid intervention contamination)
- People who have a medical contraindication to using nicotine replacement therapy:
- allergy to nicotine patch
- pregnancy or intention to become pregnant over the next 12 months
- breastfeeding
- heart attack in the past 2 months
- underlying arrhythmia
- ongoing or worsening angina.